Teva Pharmaceuticals International GmbH et al v. Mylan Laboratories Limited > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Jul 6, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per Final Judgment Order in Lead Case. CA. NO. 17-1154-CFC. (fms) |
Sep 25, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:17-cv-01154-CFC, 1:17-cv-01164-CFC, 1:17-cv-01201-CFC, 1:17-cv-01790-CFC, 1:18-cv-00117-CFC (rjb) |
Aug 10, 2018 | 20 | Redacted Document (5) Docket Text: REDACTED VERSION of [18] Proposed Consent Judgment by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
Aug 9, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [18] Proposed Consent Judgment and Stipulation of Dismissal filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 8/8/18. (ntl) |
Aug 3, 2018 | 19 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Karen E. Keller regarding Sealed Consent Judgment and Stipulation of Dismissal - re (18 in 1:17-cv-01790-LPS) Proposed Consent Judgment. (Keller, Karen) |
Jul 25, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:17-cv-01154-LPS, 1:17-cv-01164-LPS, 1:17-cv-01201-LPS, 1:17-cv-01790-LPS, 1:18-cv-00117-LPS (rjb) |
Feb 22, 2018 | N/A | Remark (0) Docket Text: Remark - These cases have been consolidated for all purposes. All future filings shall be made ONLY in Lead C.A. No. 17-1154-GMS. (mdb) |
Feb 22, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [13] Letter - This case is consolidated with Lead C.A. No. 17-1154-GMS. All future filings shall be made only in the Lead Case. The parties are directed to participate in the scheduling telephone conference set for Tuesday, February 27, 2018 at 2:00 PM (EST). Ordered by Judge Gregory M. Sleet on 2/22/2018. (mdb) |
Feb 21, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michelle L. Ernst,Kenneth G. Schuler,Marc N. Zubick,Daniel G. Brown for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
Feb 21, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The "Order re: Case Management in Civil Cases" was filed in error and has been removed from the docket. The parties are to disregard the order. (mdb) |
Feb 20, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [16] MOTION for Pro Hac Vice Appearance of Attorney Daniel G. Brown, Michelle L. Ernst, Kenneth G. Schuler, and Marc N. Zubick filed by Eagle Pharmaceuticals, Inc., [17] MOTION for Pro Hac Vice Appearance of Attorney David I. Berl and Shaun P. Mahaffy filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. Ordered by Judge Gregory M. Sleet on 2/20/2018. (mdb) |
Feb 20, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ben Picozzi for Cephalon, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
Feb 20, 2018 | 17 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David I. Berl and Shaun P. Mahaffy - filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
Feb 16, 2018 | 15 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan, Inc. for Mylan Laboratories Limited filed by Mylan Laboratories Limited. (Lennon, James) |
Feb 16, 2018 | 16 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Daniel G. Brown, Michelle L. Ernst, Kenneth G. Schuler, and Marc N. Zubick - filed by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
Feb 14, 2018 | 12 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, by Mylan Laboratories Limited.(Lennon, James) |
Feb 14, 2018 | 13 | Letter (3) Docket Text: Letter to Honorable Judge Gregory M. Sleet from James Lennon regarding January 3, 2018 Oral Order on consolidation. (Lennon, James) |
Jan 31, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [11] STIPULATION TO EXTEND TIME to Respond to the Complaint to February 14, 2018 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc., Set/Reset Answer Deadlines: Mylan Laboratories Limited answer due 2/14/2018.. Ordered by Judge Gregory M. Sleet on 1/31/2018. (mdb) |
Jan 30, 2018 | 11 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to February 14, 2018 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
Jan 24, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Nicole W. Stafford for Mylan Laboratories Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
Jan 24, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Shyamkrishna Palaiyanur,Anna G. Phillips for Mylan Laboratories Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
Jan 23, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [10] MOTION for Pro Hac Vice Appearance of Attorney Nicole Stafford, Dennis D. Gregory, Anna Grace Phillips, and Shyamkrishna Palaiyanur filed by Mylan Laboratories Limited. Ordered by Judge Gregory M. Sleet on 1/23/2018. (mdb) |
Jan 19, 2018 | 9 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by James Michael Lennon on behalf of Mylan Laboratories Limited (Lennon, James) |
Jan 19, 2018 | 10 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicole Stafford, Dennis D. Gregory, Anna Grace Phillips, and Shyamkrishna Palaiyanur - filed by Mylan Laboratories Limited. (Lennon, James) |
Jan 3, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER - The Scheduling Order entered in Consolidated Case 17-1154-GMS will apply to this case, subject to the defendant's right to object, which shall be within seven days after the filing of a response to the complaint. If no such objection is filed, this case will be consolidated for all purposes with Lead Case No. 17-1154-GMS.. Ordered by Judge Gregory M. Sleet on 1/3/2018. (mdb) |
Dec 20, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb) |
Dec 20, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (8 in 1:17-cv-01790-GMS, 21 in 1:17-cv-01154-GMS) MOTION for Pro Hac Vice Appearance of Attorney Ben V. Picozzi filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. Ordered by Judge Gregory M. Sleet on 12/20/2017. Associated Cases: 1:17-cv-01154-GMS, 1:17-cv-01790-GMS(mdb) |
Dec 14, 2017 | 8 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ben V. Picozzi - filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
Dec 13, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Mylan Laboratories Limited on 12/13/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
Dec 12, 2017 | 1 | Exhibit A-G (92) |
Dec 12, 2017 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Eagle Pharmaceuticals, Inc.. (nmg) |
Dec 12, 2017 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceuticals Industries Ltd. for Cephalon, Inc. filed by Cephalon, Inc.. (nmg) |
Dec 12, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals International GmbH filed by Teva Pharmaceuticals International GmbH. (nmg) |
Dec 12, 2017 | 4 | Patent/Trademark Report to Commissioner (3) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,609,707 B2; US 8,791,270 B2; US 9,000,021 B2; US 9,034,908 B2; US 9,144,568 B1. (nmg) |
Dec 12, 2017 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/30/2017. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 4/30/2020. (nmg) |
Dec 12, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
Dec 12, 2017 | 1 | Civil Cover Sheet (1) |
Dec 12, 2017 | 1 | Exhibit H-M (72) |
Dec 12, 2017 | 1 | Complaint* (1) |